First National Bank of Omaha Makes New $2.81 Million Investment in CME Group Inc. $CME

First National Bank of Omaha purchased a new stake in shares of CME Group Inc. (NASDAQ:CME) in the 2nd quarter, HoldingsChannel reports. The institutional investor purchased 12,727 shares of the financial services provider’s stock, valued at approximately $2,811,000.

Other hedge funds have also recently added to or reduced their stakes in the company. Empowered Funds LLC increased its position in CME Group by 11.5% during the first quarter. Empowered Funds LLC now owns 10,027 shares of the financial services provider’s stock worth $2,660,000 after buying an additional 1,037 shares during the last quarter. Marshall Wace LLP boosted its stake in shares of CME Group by 103.1% during the 2nd quarter. Marshall Wace LLP now owns 3,692 shares of the financial services provider’s stock worth $1,018,000 after acquiring an additional 121,707 shares in the last quarter. Federated Hermes Inc. increased its holdings in shares of CME Group by 1,325.2% during the 2nd quarter. Federated Hermes Inc. now owns 23,572 shares of the financial services provider’s stock valued at $6,497,000 after acquiring an additional 21,918 shares during the last quarter. Nebula Research & Development LLC bought a new position in shares of CME Group in the 2nd quarter valued at approximately $992,000. Finally, The Manufacturers Life Insurance Company raised its stake in shares of CME Group by 2.6% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 287,876 shares of the financial services provider’s stock valued at $79,344,000 after acquiring an additional 7,397 shares in the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

CME Group Stock Up 1.4%

CME opened at $271.54 on Wednesday. CME Group Inc. has a fifty-two week low of $218.31 and a fifty-two week high of $329.16. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02. The firm’s fifty day moving average price is $250.82 and its two-hundred day moving average price is $279.97. The company has a market capitalization of $97.64 billion, a P/E ratio of 23.03, a P/E/G ratio of 3.14 and a beta of 0.23.

CME Group (NASDAQ:CME) last announced its quarterly earnings data on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.91 by $0.08. CME Group had a net margin of 63.30% and a return on equity of 15.60%. The company had revenue of $1.71 billion during the quarter, compared to analysts’ expectations of $1.68 billion. During the same quarter in the prior year, the company posted $2.96 EPS. The business’s revenue was up .8% on a year-over-year basis. On average, analysts anticipate that CME Group Inc. will post 12.27 EPS for the current year.

CME Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, September 25th. Stockholders of record on Wednesday, September 9th will be paid a $1.30 dividend. This represents a $5.20 annualized dividend and a dividend yield of 1.9%. The ex-dividend date is Wednesday, September 9th. CME Group’s dividend payout ratio is currently 44.11%.

Insider Activity at CME Group

In related news, Director William R. Shepard purchased 325 shares of the firm’s stock in a transaction that occurred on Thursday, June 25th. The shares were acquired at an average price of $230.57 per share, with a total value of $74,935.25. Following the purchase, the director directly owned 260,442 shares in the company, valued at $60,050,111.94. This represents a 0.12% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. 0.30% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on CME. Piper Sandler decreased their target price on CME Group from $329.00 to $295.00 and set an “overweight” rating for the company in a research report on Wednesday, July 15th. Erste Group Bank downgraded shares of CME Group from a “buy” rating to a “hold” rating in a report on Friday, June 5th. The Goldman Sachs Group dropped their target price on shares of CME Group from $267.00 to $245.00 and set a “sell” rating on the stock in a report on Tuesday, June 30th. Bank of America raised their price target on CME Group from $226.00 to $230.00 and gave the company an “underperform” rating in a research report on Thursday, July 23rd. Finally, Deutsche Bank Aktiengesellschaft dropped their price objective on CME Group from $342.00 to $322.00 and set a “buy” rating on the stock in a research note on Thursday, April 23rd. Ten investment analysts have rated the stock with a Buy rating, five have assigned a Hold rating and three have assigned a Sell rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $291.81.

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.